Статті в журналах з теми "Antifibrotics"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Antifibrotics".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Niitsu, Takayuki, Kiyoharu Fukushima, Sho Komukai, So Takata, Yuko Abe, Takuro Nii, Tomoki Kuge, et al. "Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease." RMD Open 9, no. 1 (January 2023): e002667. http://dx.doi.org/10.1136/rmdopen-2022-002667.
Повний текст джерелаBos, Saskia, Laurens J. De Sadeleer, Arno Vanstapel, Hanne Beeckmans, Annelore Sacreas, Jonas Yserbyt, Wim A. Wuyts, and Robin Vos. "Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review." European Respiratory Review 30, no. 160 (June 1, 2021): 210050. http://dx.doi.org/10.1183/16000617.0050-2021.
Повний текст джерелаSoskis, Alyssa, and Robert Hallowell. "Antifibrotic Therapy: Is There a Role in Myositis-Interstitial Lung Disease?" Respiration 100, no. 9 (2021): 923–32. http://dx.doi.org/10.1159/000515607.
Повний текст джерелаJegal, Yangjin, Jong Sun Park, Song Yee Kim, Hongseok Yoo, Sung Hwan Jeong, Jin Woo Song, Jae Ha Lee, et al. "Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry." Tuberculosis and Respiratory Diseases 85, no. 2 (April 1, 2022): 185–94. http://dx.doi.org/10.4046/trd.2021.0123.
Повний текст джерелаCaliskan, Canay, Benjamin Seeliger, Benedikt Jäger, Jan Fuge, Tobias Welte, Oliver Terwolbeck, Julia Freise, Coline H. M. van Moorsel, Yingze Zhang, and Antje Prasse. "Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis—Part B." Journal of Clinical Medicine 9, no. 6 (June 25, 2020): 1993. http://dx.doi.org/10.3390/jcm9061993.
Повний текст джерелаDhar, Raja. "Antifibrotics in India." Lung India 36, no. 5 (2019): 445. http://dx.doi.org/10.4103/lungindia.lungindia_379_19.
Повний текст джерелаAlbera, Carlo, Giulia Verri, Federico Sciarrone, Elena Sitia, Mauro Mangiapia, and Paolo Solidoro. "Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective." Biomedicines 9, no. 9 (September 16, 2021): 1237. http://dx.doi.org/10.3390/biomedicines9091237.
Повний текст джерелаBoleto, Gonçalo, Jérôme Avouac, and Yannick Allanore. "The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease." Therapeutic Advances in Musculoskeletal Disease 14 (January 2022): 1759720X2110666. http://dx.doi.org/10.1177/1759720x211066686.
Повний текст джерелаCohen-Naftaly, Michal, and Scott L. Friedman. "Current status of novel antifibrotic therapies in patients with chronic liver disease." Therapeutic Advances in Gastroenterology 4, no. 6 (July 22, 2011): 391–417. http://dx.doi.org/10.1177/1756283x11413002.
Повний текст джерелаTzilas, Vasilios, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, and Demosthenes Bouros. "Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study." ERJ Open Research 6, no. 4 (October 2020): 00152–2020. http://dx.doi.org/10.1183/23120541.00152-2020.
Повний текст джерелаMajewski, Sebastian, Maria Królikowska, Ulrich Costabel, Wojciech J. Piotrowski, and Marek Ochman. "Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy." Case Reports in Pulmonology 2022 (August 13, 2022): 1–5. http://dx.doi.org/10.1155/2022/4054339.
Повний текст джерелаPockros, Paul J. "Antifibrotics for Chronic Hepatitis C." Clinics in Liver Disease 13, no. 3 (August 2009): 365–73. http://dx.doi.org/10.1016/j.cld.2009.05.005.
Повний текст джерелаWright, William Alexander, Louise E. Crowley, Dhruv Parekh, Anjali Crawshaw, Davinder P. Dosanjh, Peter Nightingale, and David R. Thickett. "Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis." BMJ Open Respiratory Research 8, no. 1 (March 2021): e000782. http://dx.doi.org/10.1136/bmjresp-2020-000782.
Повний текст джерелаIftikhar, Imran H. "Antifibrotics and All-Cause Mortality Rates." Chest 161, no. 5 (May 2022): e330-e331. http://dx.doi.org/10.1016/j.chest.2021.12.660.
Повний текст джерелаFallowfield, Jonathan A. "Therapeutic targets in liver fibrosis." American Journal of Physiology-Gastrointestinal and Liver Physiology 300, no. 5 (May 2011): G709—G715. http://dx.doi.org/10.1152/ajpgi.00451.2010.
Повний текст джерелаTaweesedt, Pahnwat, Ploypin Lertjitbanjong, Dararat Eksombatchai, Prangthip Charoenpong, Teng Moua, Charat Thongprayoon, Supawit Tangpanithandee, and Tananchai Petnak. "Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis." Journal of Clinical Medicine 12, no. 2 (January 13, 2023): 655. http://dx.doi.org/10.3390/jcm12020655.
Повний текст джерелаLaCamera, Peter P., Susan L. Limb, Tmirah Haselkorn, Elizabeth A. Morgenthien, John L. Stauffer, and Mark L. Wencel. "Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis." Chronic Respiratory Disease 16 (January 1, 2019): 147997311987967. http://dx.doi.org/10.1177/1479973119879678.
Повний текст джерелаGuler, Sabina A., and Manuela Funke-Chambour. "Antifibrotics: Shrinking the Box of Therapeutic Uncertainty." Respiration 97, no. 3 (November 19, 2018): 202–4. http://dx.doi.org/10.1159/000494275.
Повний текст джерелаLama, Paul J., and Robert D. Fechtner. "Antifibrotics and Wound Healing in Glaucoma Surgery." Survey of Ophthalmology 48, no. 3 (May 2003): 314–46. http://dx.doi.org/10.1016/s0039-6257(03)00038-9.
Повний текст джерелаCheng, Shih-Lung, Chau-Chyun Sheu, Chih-Feng Chian, Jeng-Yuan Hsu, Kuo-Chin Kao, Liang-Wen Hang, Ching-Hsiung Lin, Wen-Feng Fang, Hao-Chien Wang, and Diahn-Warng Perng. "NICEFIT—A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan." Biomedicines 10, no. 10 (September 22, 2022): 2362. http://dx.doi.org/10.3390/biomedicines10102362.
Повний текст джерелаIommi, Marica, Andrea Faragalli, Martina Bonifazi, Federico Mei, Lara Letizia Latini, Marco Pompili, Flavia Carle, and Rosaria Gesuita. "Prognosis and Survival in Idiopathic Pulmonary Fibrosis in the Era of Antifibrotic Therapy in Italy: Evidence from a Longitudinal Population Study Based on Healthcare Utilization Databases." International Journal of Environmental Research and Public Health 19, no. 24 (December 12, 2022): 16689. http://dx.doi.org/10.3390/ijerph192416689.
Повний текст джерелаIswandana, Raditya, Bao Tung Pham, Su Suriguga, Theerut Luangmonkong, Louise A. van Wijk, Yvette J. M. Jansen, Dorenda Oosterhuis, Henricus Antonius Maria Mutsaers, and Peter Olinga. "Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs." Inflammatory Bowel Diseases 26, no. 5 (January 14, 2020): 678–86. http://dx.doi.org/10.1093/ibd/izz329.
Повний текст джерелаAlbrecht, Katinka, Anja Strangfeld, Ursula Marschall, and Johanna Callhoff. "Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020." RMD Open 9, no. 1 (January 2023): e002777. http://dx.doi.org/10.1136/rmdopen-2022-002777.
Повний текст джерелаMishra, Mayank, and Girish Sindhwani. "Antifibrotics for COVID-19 related lung fibrosis: Agents with benefits?" Advances in Respiratory Medicine 89, no. 2 (April 30, 2021): 231–33. http://dx.doi.org/10.5603/arm.a2021.0023.
Повний текст джерелаRamachandran, Prakash, and Neil C. Henderson. "Antifibrotics in chronic liver disease: tractable targets and translational challenges." Lancet Gastroenterology & Hepatology 1, no. 4 (December 2016): 328–40. http://dx.doi.org/10.1016/s2468-1253(16)30110-8.
Повний текст джерелаAntoniou, Katerina M., Athina Trachalaki, Argyris Tzouvelekis, Venerino Poletti, Eirini Vasarmidi, Petros Sfikakis, and Demosthenes Bouros. "A role of antifibrotics in the treatment of Scleroderma-ILD?" Pulmonology 26, no. 1 (January 2020): 1–2. http://dx.doi.org/10.1016/j.pulmoe.2019.08.004.
Повний текст джерелаWilfong, Erin M., and Rohit Aggarwal. "Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease." Therapeutic Advances in Musculoskeletal Disease 13 (January 2021): 1759720X2110609. http://dx.doi.org/10.1177/1759720x211060907.
Повний текст джерелаRockey, Don C. "New Therapies in Hepatitis C Virus and Chronic Liver Disease: Antifibrotics." Clinics in Liver Disease 10, no. 4 (November 2006): 881–900. http://dx.doi.org/10.1016/j.cld.2006.08.019.
Повний текст джерелаBansal, Meena B., and Naichaya Chamroonkul. "Antifibrotics in liver disease: are we getting closer to clinical use?" Hepatology International 13, no. 1 (October 9, 2018): 25–39. http://dx.doi.org/10.1007/s12072-018-9897-3.
Повний текст джерелаTorrisi, Sebastiano Emanuele, Mauro Pavone, Ada Vancheri, and Carlo Vancheri. "When to start and when to stop antifibrotic therapies." European Respiratory Review 26, no. 145 (September 30, 2017): 170053. http://dx.doi.org/10.1183/16000617.0053-2017.
Повний текст джерелаBansal, Ruchi, Beata Nagórniewicz, and Jai Prakash. "Clinical Advancements in the Targeted Therapies against Liver Fibrosis." Mediators of Inflammation 2016 (2016): 1–16. http://dx.doi.org/10.1155/2016/7629724.
Повний текст джерелаLiang, Minrui, Eric L. Matteson, Andy Abril, and Jörg H. W. Distler. "The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease." Therapeutic Advances in Musculoskeletal Disease 14 (January 2022): 1759720X2210744. http://dx.doi.org/10.1177/1759720x221074457.
Повний текст джерелаRohner, Nathan A., Dung Nguyen, and Horst A. von Recum. "Affinity Effects on the Release of Non-Conventional Antifibrotics from Polymer Depots." Pharmaceutics 12, no. 3 (March 17, 2020): 275. http://dx.doi.org/10.3390/pharmaceutics12030275.
Повний текст джерелаAli, Mohamed, Ashley M. Egan, Gaja F. Shaughnessy, Harika Dasari, Virginia P. Van Keulen, Marie Christine Aubry, Andrew H. Limper, Tobias Peikert, and Eva M. Carmona. "Antifibrotics Modify B-cell Induced Fibroblast Migration and Activation in IPF Patients." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 234.18. http://dx.doi.org/10.4049/jimmunol.204.supp.234.18.
Повний текст джерелаSuissa, Samy, and Deborah Assayag. "Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias?" European Respiratory Journal 57, no. 3 (March 2021): 2004562. http://dx.doi.org/10.1183/13993003.04562-2020.
Повний текст джерелаKo, Audrey C. "Ablative laser assisted topical delivery of antifibrotics in the management of cicatricial ectropion." World Journal of Ophthalmology 4, no. 2 (2014): 7. http://dx.doi.org/10.5318/wjo.v4.i2.7.
Повний текст джерелаCilli, Aykut, Fatih Uzer, Can Sevinç, Funda Coşkun, Ahmet Ursavaş, Şükriye Öner, and Fırat Kose. "Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis." Pulmonary Pharmacology & Therapeutics 71 (December 2021): 102099. http://dx.doi.org/10.1016/j.pupt.2021.102099.
Повний текст джерелаBansal, Meena B., and Naichaya Chamroonkul. "Correction to: Antifibrotics in liver disease: are we getting closer to clinical use?" Hepatology International 13, no. 1 (January 2019): 40–41. http://dx.doi.org/10.1007/s12072-018-09924-1.
Повний текст джерелаKuzubova, N. A., O. N. Titova, E. S. Lebedeva, and E. V. Volchkova. "Pulmonary fibrosis associated with COVID-19." Russian Medical Inquiry 5, no. 7 (2021): 492–96. http://dx.doi.org/10.32364/2587-6821-2021-5-7-492-496.
Повний текст джерелаKumar, Naresh. "Post-COVID-19 Pulmonary Fibrosis: An Update." Journal of Advanced Research in Medicine 08, no. 02 (June 30, 2021): 16–26. http://dx.doi.org/10.24321/2349.7181.202109.
Повний текст джерелаHage, René, and Macé M. Schuurmans. "COVID-19-Associated Lung Fibrosis: Two Pathways and Two Phenotypes, Lung Transplantation, and Antifibrotics." Transplantology 3, no. 3 (July 6, 2022): 230–40. http://dx.doi.org/10.3390/transplantology3030024.
Повний текст джерелаAssayag, Deborah. "Broad Adoption of Antifibrotics in Idiopathic Pulmonary Fibrosis: Still a Long Way to Go." Annals of the American Thoracic Society 18, no. 7 (July 2021): 1115–16. http://dx.doi.org/10.1513/annalsats.202102-123ed.
Повний текст джерелаLambers, Christopher, Panja M. Boehm, Silvia Lee, Fabio Ius, Peter Jaksch, Walter Klepetko, Igor Tudorache, Robin Ristl, Tobias Welte, and Jens Gottlieb. "Effect of antifibrotics on short-term outcome after bilateral lung transplantation: a multicentre analysis." European Respiratory Journal 51, no. 6 (April 20, 2018): 1800503. http://dx.doi.org/10.1183/13993003.00503-2018.
Повний текст джерелаDhwani Patel, Prutha Patel, Neel Raval, and Jagdish Kakadiya. "Post Covid-19 pulmonary fibrosis: A review article." International Journal of Biological and Pharmaceutical Sciences Archive 4, no. 1 (September 30, 2022): 040–45. http://dx.doi.org/10.53771/ijbpsa.2022.4.1.0048.
Повний текст джерелаAli, Mohamed F., Ashley M. Egan, Gaja F. Shaughnessy, Dagny K. Anderson, Theodore J. Kottom, Harika Dasari, Virginia P. Van Keulen, et al. "Antifibrotics Modify B-Cell–induced Fibroblast Migration and Activation in Patients with Idiopathic Pulmonary Fibrosis." American Journal of Respiratory Cell and Molecular Biology 64, no. 6 (June 2021): 722–33. http://dx.doi.org/10.1165/rcmb.2020-0387oc.
Повний текст джерелаNaibey, Rosdiana, Widya Wasityastuti, Nungki Anggorowati, and Nur Arfian. "Antifibrotics and Antioxidants of Chlorogenic Acid Inhibits Toll- Like Receptors-4 as Liver Fibrotic Marker." Green Medical Journal 3, no. 2 (August 31, 2021): 91–99. http://dx.doi.org/10.33096/gmj.v3i2.86.
Повний текст джерелаBendstrup, Elisabeth, and Meena Kalluri. "Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics." Drug Safety 43, no. 10 (August 20, 2020): 953–55. http://dx.doi.org/10.1007/s40264-020-00991-8.
Повний текст джерелаIswandana, Raditya, Bao Tung Pham, Theerut Luangmonkon, Henricus A. M. Mutsaers, and Peter Olinga. "ID2033 Precision-cut tissue slices as a novel ex-vivo model for evaluating the efficacy of potential drugs." Biomedical Research and Therapy 4, S (September 5, 2017): 63. http://dx.doi.org/10.15419/bmrat.v4is.272.
Повний текст джерелаJoannes, A., C. Morzadec, F. Llamas Gutierrez, B. Richard De Latour, L. Wollin, S. Jouneau, and L. Vernhet. "Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases." Revue des Maladies Respiratoires 39, no. 2 (February 2022): 128–29. http://dx.doi.org/10.1016/j.rmr.2022.02.048.
Повний текст джерелаTezel, G??lg??n, Allan E. Kolker, Michael A. Kass, and Martin B. Wax. "Late Removal of Releasable Sutures After Trabeculectomy or Combined Trabeculectomy With Cataract Extraction Supplemented With Antifibrotics." Journal of Glaucoma 7, no. 2 (April 1998): 75???81. http://dx.doi.org/10.1097/00061198-199804000-00002.
Повний текст джерела